Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
NervGen, a NASDAQ-listed biopharmaceutical company, announced its inaugural R&D Day webcast to provide a comprehensive update on its lead neuroreparative drug candidate NVG-291. The event will feature detailed presentations on the science, clinical data, and upcoming Phase 3 RESTORE trial designed to treat chronic cervical spinal cord injury. Exper…
FTI Consulting, Inc. has appointed Luis Roman as Senior Managing Director to strengthen its Construction, Projects & Assets practice, particularly in Latin America. Mr. Roman brings over 30 years of construction and project management experience with expertise in construction forensics and dispute resolution. His appointment aims to support clients…
Helus Pharma, a clinical-stage pharmaceutical company focusing on novel serotonergic agonists (NSAs) for mental health conditions, announced that its CEO Michael Halstead will participate in a fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference. The company is advancing its lead compounds HLP003 in Phase 3 for major depres…
The Kremlin said it hopes U.S.-mediated negotiations aimed at ending the war in Ukraine will restart soon. Kremlin spokesman Dmitry Peskov cited a "confirmed political will" to resume talks and said contacts with U.S. counterparts continue following negotiator visits and a telephone call between the presidents. Prisoner exchanges between Russia and…
U.S. stock futures traded below the flatline early Wednesday as oil crossed the $100-per-barrel threshold and traders awaited inflation data that could reinforce expectations for a Federal Reserve rate increase later this month. Several corporate-specific developments drove outsized premarket moves, including Meta Platforms' rollout of an autonomou…
Orion180 Insurance Group Inc., a rapidly growing specialty insurance provider focused on homeowners and flood insurance, announced the launch of its initial public offering (IPO) of up to 20 million shares on the Nasdaq under the ticker OIG. The offering is expected to price between $15.00 and $17.00 per share. Orion180 utilizes a proprietary techn…
Coloplast shares slid following a substantial downgrade from JPMorgan, which shifted its rating to Underweight and lowered its December 2027 price target to DKK 377 from DKK 484. The bank highlighted a stretched valuation, potential changes to mid-term targets under new leadership, and weakened margins in the third quarter as primary concerns, cont…
TransUnion released findings from a Forrester-commissioned study showing increased frequency and impact of cyberattacks, with 60% of organizations experiencing at least one material incident in the past 18 months. The study highlights gaps in incident response readiness, the need for expert partners, and strategies to improve organizational resilie…
Sunbelt Rentals Holdings Inc. shares climbed in pre-market trading after the company reported record first-quarter fiscal 2027 results, with rental revenue rising 11.2% and revenue beating analyst expectations for the period ended July 31, 2026. Management increased full-year fiscal 2027 guidance and announced a regular quarterly dividend; the rece…
Futures tied to Canada's principal exchange declined on Wednesday as Brent crude climbed above $100 a barrel, fueling inflation concerns. Escalating trade tensions between the U.S. and Canada, recent attacks linked to Iran and fresh signs of weakness in major equity benchmarks kept traders cautious ahead of key U.S. inflation figures and coming cen…
KLA Corporation (KLAC) offers a disciplined buy-the-dip opportunity after a retracement from its 2026 highs. The stock sits above short-term moving averages, shows bullish MACD momentum and benefits from secular semiconductor equipment demand. Trade plan: enter at $185.84, stop at $176.00, target $235.00 for a mid-term swing (45 trading days) with …
Oddity Tech shares jumped 23.8% in pre-market trading after the beauty and wellness technology company posted second-quarter 2026 adjusted EBITDA of $13 million, surpassing its own $8–$10 million guidance, and issued a materially improved outlook for the third quarter. Management highlighted shrinking revenue declines, stronger EBITDA guidance, siz…
Chime's agreement to buy Stride for $590 million and obtain a national bank charter sent its shares up 10% premarket. The acquisition, expected to close in the first half of 2027, is projected to deliver more than $100 million in net synergies and give Chime enhanced control over product development, lower funding costs and room to expand lending, …
Kratos is carving out a low-cost, high-volume niche in unmanned systems and national-security hardware. Recent Q2 beats and raised guidance show demand; the stock has been punished and sits near its 52-week low. This trade targets a mid-term rebound tied to contract conversion and backlog realization while respecting program and cash-flow risks.
J.Jill Inc. stock rallied sharply in pre-market trading after the company reported second-quarter fiscal 2026 results that beat Wall Street estimates on both earnings and revenue, raised its full-year outlook, and announced an added quarterly cash dividend. Management cited strategic progress and a meaningful benefit from tariff refunds that bolste…
Two months before the U.S. midterm elections, markets display an unusual mix of apparent calm and underlying vulnerability. Equities sit near record highs, volatility gauges have fallen toward 2026 lows, and cross-stock correlations are unusually low, suggesting independent moves across names. Yet a range of upcoming catalysts - from economic relea…
Gilat Satellite Networks announced that its subsidiary, Gilat DataPath, received an over $32 million order from the U.S. Department of War for multi-band Deployable Ku/Ka/X-band Earth Terminals (DKET) systems. These relocatable ground platforms support rapid deployment and resilience in mission-critical defense communications, reinforcing Gilat Def…
Bilibili Inc. has completed a $500 million offering of convertible senior notes due 2031, alongside a concurrent equity placement and share repurchases. The offering involved qualified institutional buyers outside the US, and Tencent subscribed to an additional $200 million in notes subject to shareholder approval. The company also repurchased shar…
Meta Platforms rallied in pre-market trade after the company launched Muse, an autonomous AI personal agent, and followed up a model upgrade with institutional buying by Pershing Square. The combined developments appear to have driven the stock higher despite broader market weakness, prompting investors to reconsider the monetization path for Meta'…
Melius Research says an extended shutdown at Saudi Arabia's Jizan petroleum and power complex is contributing to rising oil prices. The facility has been offline for six weeks and the firm notes the closure reduces refining capacity at a time when U.S. fuel inventories are low and Brent crude has climbed to about $98 per barrel.
Can-Fite BioPharma announced publication of a peer-reviewed case report detailing the successful treatment of a patient with advanced decompensated liver cirrhosis using their drug Namodenoson, resulting in resolution of ascites and regression of esophageal varices. The patient remained clinically stable for 28 months on treatment before undergoing…
OKYO Pharma Limited announced presentations at the Ophthalmology Futures European Forum and ESCRS iNovation Day, highlighting the advancement of its lead drug urcosimod in treating neuropathic corneal pain. The company also reported positive feedback from the FDA validating its regulatory pathway and a strengthened cash position, supporting the upc…
Cocrystal Pharma announced that the last subject has been dosed in its Phase 1b norovirus challenge study evaluating CDI-988 as a preventive and treatment for norovirus infections. This study is the first clinical trial of a direct-acting antiviral specifically targeting norovirus, aiming to address a significant unmet medical need. CDI-988 has sho…
Eledon Pharmaceuticals announced an upcoming oral presentation at the International Congress of The Transplantation Society showcasing long-term safety and efficacy data of its lead investigational drug, tegoprubart, for preventing kidney transplant rejection. The data come from the Phase 2 BESTOW trial and its extension, highlighting the drug's po…
Xanadu Quantum Technologies Limited has entered into a collaboration with ASML to develop advanced lithography techniques aimed at reducing optical losses in photonic quantum computing chips. This partnership seeks to address critical challenges in achieving fault-tolerant and error-corrected quantum hardware, accelerating progress toward utility-s…
